ArticlePediatric blood & cancer2023

High burden of clinically significant adverse events associated with contemporary therapy for pediatric T-cell acute lymphoblastic leukemia/lymphoma.

Ryan J Summers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.